Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alkermes plc - Ordinary Shares (NQ:ALKS)

29.40 +0.43 (+1.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,365,561
Open 29.11
Bid (Size) 29.50 (1)
Ask (Size) 29.80 (2)
Prev. Close 28.97
Today's Range 29.09 - 29.75
52wk Range 25.56 - 36.45
Shares Outstanding 166,121,384
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ALKERMES PLC (NASDAQ:ALKS) Emerges as a Top Value Pick with Strong Fundamentals and Undervalued Metrics
ALKERMES PLC (ALKS) is a strong value stock with low P/E ratios, high profitability, and a debt-free balance sheet, making it an attractive pick for long-term investors. 
Via Chartmill
Alkermes PLC (NASDAQ:ALKS) Surges 7.8% Pre-Market After Q2 2025 Earnings Beat Revenue and EPS Estimates
Alkermes PLC (ALKS) reported strong Q2 2025 results, beating revenue and EPS estimates, driving a 7.8% pre-market rally. The company reaffirmed full-year guidance, signaling confidence in growth. 
Via Chartmill
Topics Earnings

Performance

YTD
+2.3%
+2.3%
1 Month
+10.4%
+10.4%
3 Month
-6.0%
-6.0%
6 Month
-16.9%
-16.9%
1 Year
+4.6%
+4.6%

More News

Read More
Alkermes Q2 Sales Up 14 Percent
Via The Motley Fool
Topics Intellectual Property
Earnings Scheduled For July 29, 2025
Via Benzinga
Alkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.
Via Investor's Business Daily
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
Earnings Scheduled For May 1, 2025
Via Benzinga
NASDAQ:ALKS: good value for what you're paying.
Via Chartmill
Earnings Scheduled For February 12, 2025
Via Benzinga
Despite its impressive fundamentals, NASDAQ:ALKS remains undervalued.
Via Chartmill
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Via Benzinga
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
Via Benzinga
Biogen Shares Slip After $46M Research Charge Hits Quarterly Profit
Via Stocktwits
ALKERMES PLC (NASDAQ:ALKS) – A Potential Undervalued Opportunity in Biopharma
Via Chartmill
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
NASDAQ:ALKS, an undervalued stock with good fundamentals.
Via Chartmill
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
Via Benzinga
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Via Benzinga
This Arista Networks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Alkermes Stock
Via Benzinga
In a market where value is scarce, ALKERMES PLC (NASDAQ:ALKS) offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
What 5 Analyst Ratings Have To Say About Alkermes
Via Benzinga
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Alkermes Plc EPS Soars Past Forecasts
Via The Motley Fool
NASDAQ:ALKS is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill

Frequently Asked Questions

Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 29.40
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 09/02/25 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 4.88B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.